Acute side effects after definitive stereotactic body radiation therapy (SBRT) for patients with clinically localized or locally advanced prostate cancer: a single institution prospective study
The aim of the study was to evaluate acute side effects after extremely hypofractionated intensity-modulated radiotherapy (IMRT) with stereotactic body radiation therapy (SBRT) for definitive treatment of prostate cancer patients.
Guardado en:
Autores principales: | Jorgo Kliton, Polgar Csaba, Stelczer Gabor, Major Tibor, Gesztesi Laszlo, Agoston Peter |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Sciendo
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8f26f04ca856431fba161f82bb7d31e0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial
por: Constantinos Zamboglou, et al.
Publicado: (2021) -
Bibliometric Analysis of the Top-Cited Publications and Research Trends for Stereotactic Body Radiotherapy
por: Yanhao Liu, et al.
Publicado: (2021) -
Bothersome Hematospermia Following Stereotactic Body Radiation Therapy for Prostate Cancer
por: Sarthak Shah, et al.
Publicado: (2021) -
Novel Approach of Linear Accelerator-Based Stereotactic Radiosurgery in an Adult Patient With Brain Arteriovenous Malformation: A Case Report and Clinical Outcome
por: Santosh Devarakonda, et al.
Publicado: (2020) -
Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient population
por: Potkrajcic Vlatko, et al.
Publicado: (2021)